Washington: A monoclonal antibody therapy developed by MassBiologics of the University of Massachusetts Medical School (UMMS) and tested in an animal model at the Texas Biomedical Research Institute, prevents infection by the hepatitis C virus (HCV).Researchers found that the human monoclonal antibody targeting the virus protected chimpanzees from HCV infection in a dose-dependent manner in a study conducted at Texas Biomed’s Southwest National Primate Research Center in San Antonio.
Decision to form govt in Delhi on Monday: Arvind Kejriwal
Modi`s wax statue unveiled in Mumbai
Will AAP form govt on Monday?
Lieutenant Governor Najeeb Jung recommends President`s rule in Delhi